{"url_path":"/fda/drug/recalls/D-0499-2026","section_key":"summary","section_title":"DRUG Recall: SCOPE HEALTH — Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, Manufactured for Scope Health Inc., 79 Madison Ave., 8th Floor, New York, NY 10016, USA, NDC 72972-002-01.","topic":"fda","document":{"doc_type":"drug-recall","doc_date":"2026-04-20","source_url":"https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0499-2026%22","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"SCOPE HEALTH"},"word_count":105,"has_tables":false,"body_markdown":"# FDA DRUG Recall: D-0499-2026\n\n**Recalling firm:** SCOPE HEALTH\n**Classification:** Class II\n**Status:** Ongoing\n**Type:** Voluntary: Firm initiated\n**Initiated:** 2026-04-20\n**Report date:** 2026-05-06\n\n## Product\nOptase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, Manufactured for Scope Health Inc., 79 Madison Ave., 8th Floor, New York, NY 10016, USA, NDC 72972-002-01.\n\n## Reason\nLack of Assurance of Sterility\n\n## Affected lots\nLot#: 8T98, 9T31, 9T32, Exp. Date: 30/04/26; 2V13, 2V14, 2V15, Exp. Date 30/06/26; 3V35, Exp. Date 31/08/26;3V36, 3V37, Exp. Date 30/09/26;  5V45, 5V46, 9V12, Exp. Date 31/03/27; 1X57, 1X70, 1X84, Exp. Date 31/05/27.\n\n## Distribution\nNationwide within the United States"}